PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-2.16%
Both yoy net incomes decline, with MCHP at -16.42%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-2.53%
Both reduce yoy D&A, with MCHP at -13.52%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-314.29%
Negative yoy deferred tax while MCHP stands at 88.64%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
48.72%
SBC growth well above MCHP's 2.80%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-341.33%
Both reduce yoy usage, with MCHP at -70.96%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-198.60%
Both yoy AR lines negative, with MCHP at -81.17%. Martin Whitman would suspect an overall sector lean approach or softer demand.
30.74%
Inventory shrinking or stable vs. MCHP's 370.59%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-239.08%
Negative yoy AP while MCHP is 66.88%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-200.33%
Negative yoy usage while MCHP is 114.98%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-6000.00%
Negative yoy while MCHP is 13.01%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-57.51%
Both yoy CFO lines are negative, with MCHP at -12.30%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
5.79%
Some CapEx rise while MCHP is negative at -65.05%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
28.82%
Purchases growth of 28.82% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
No Data
No Data available this quarter, please select a different quarter.
11.34%
We have some outflow growth while MCHP is negative at -97.96%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
104.07%
We have mild expansions while MCHP is negative at -76.26%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-150.00%
We cut debt repayment yoy while MCHP is 43.29%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
35.63%
We slightly raise equity while MCHP is negative at -46.31%. John Neff sees competitor possibly preserving share count or buying back shares.
-21.60%
We cut yoy buybacks while MCHP is 81.23%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.